Disc Medicine (IRON) Change in Acquisitions & Divestments (2024 - 2026)
Disc Medicine (IRON) reported Change in Acquisitions & Divestments of $152.1 million for Q1 2026, up 101.5% year-over-year from $75.5 million in Q1 2025, and up 12.31% on a QoQ basis from $135.4 million in Q4 2025.
Disc Medicine (IRON) has 3 years of Change in Acquisitions & Divestments data on file, last reported at $152.1 million in Q1 2026.
- Quarterly Change in Acquisitions & Divestments rose 101.5% year-over-year to $152.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $532.8 million (up 212.93% YoY) and the FY2025 annual result came in at $456.2 million, up 381.24% from the prior year.
- Change in Acquisitions & Divestments rose to $152.1 million in Q1 2026 per IRON's latest filing, from $135.4 million in the prior quarter.
- Across five years, Change in Acquisitions & Divestments topped out at $152.1 million in Q1 2026 and bottomed at $23.0 million in Q3 2024.
- The 3-year median for Change in Acquisitions & Divestments is $110.4 million (2025), against an average of $100.4 million.
- Peak annual rise in Change in Acquisitions & Divestments reached 486.96% in 2025, while the deepest fall reached 88.58% in 2025.
- Tracing IRON's Change in Acquisitions & Divestments over 3 years: stood at $71.8 million in 2024, then soared by 88.58% to $135.4 million in 2025, then grew by 12.31% to $152.1 million in 2026.
- Per Business Quant, the three latest IRON Change in Acquisitions & Divestments figures stand at $152.1 million (Q1 2026), $135.4 million (Q4 2025), and $135.0 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Disc Medicine | 2.76 Bn | 2.03 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 152.07 Mn |
| Mar 31, 2026 | 152.07 Mn |
| Dec 31, 2025 | 135.40 Mn |
| Dec 31, 2025 | 135.40 Mn |
| Sep 30, 2025 | 135.00 Mn |
| Sep 30, 2025 | 135.00 Mn |
| Jun 30, 2025 | 110.35 Mn |
| Jun 30, 2025 | 110.35 Mn |
| Mar 31, 2025 | 75.47 Mn |
| Mar 31, 2025 | 75.47 Mn |
| Dec 31, 2024 | 71.80 Mn |
| Dec 31, 2024 | 71.80 Mn |
| Sep 30, 2024 | 23.00 Mn |
| Sep 30, 2024 | 23.00 Mn |